Rekvina Laboratories Fair Value

Average Fair Value
₹9.29
Current Market Price: ₹71.2
-86.95% Price Difference

Rekvina Laboratories fair value. Rekvina Laboratories (VINRKLB) average fair value is ₹9.29 across 1 valuation models — Price-to-Sales Valuation, vs a current market price of ₹71.2 (-86.95%), fair value range ₹9.29–₹9.29. For live price and a broader fundamental view, visit VINRKLB screener.

Fair Value Analysis Export

VINRKLB Fair Value vs Current Price — Valuation Summary

VINRKLB average fair value, fair value range, price gap and valuation status across 1 models: Price-to-Sales Valuation. Analyse VINRKLB shareholding pattern to track promoter, FII and institutional holdings.

Average Fair Value
₹9.29
Current Market Price
₹71.2
Price Difference
₹-61.91
Percentage Difference
-86.95%
Fair Value Range
₹9.29 - ₹9.29
Methods Used
1
Analysis based on 1 valuation methods: Price-to-Sales Valuation

Price-to-Sales Valuation

Revenue/Share ₹2.32
Sector Avg P/S 4.0
Fair Value
₹9.29

VINRKLB Fair Value Analysis — Data Sources & Coverage

Rekvina Laboratories financial data sources, valuation methods applied and sector benchmarks used.

Methods Used
1
Sector
Healthcare

Available Data Sources: Financial statements, balance sheet data , sector comparisons.

VINRKLB vs Healthcare Sector Peers — P/E, P/B & Market Cap

Rekvina Laboratories P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Pharmaids Pharmaceuticals PHARMAID -22.2 2.05 ₹98
Syngene International SYNGENE 89.5 3.43 ₹16,631
Emcure Pharmaceuticals EMCURE 35.0 7.21 ₹37,498
Glen Industries GLEN 15.2 1.9 ₹248
Broach Lifecare Hospital BROACH 90.7 0.82 ₹8

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.